The present study supports this hypothesis, as ANGPTL2 deficiency reduced inflammation across multiple organs and attenuated obesity‐induced cardiac dysfunction, kidney fibrosis, and adipocyte hypertrophy. This evidence concerns the gene ANGPTL2 and Obesity.